Table 1.
Category | Definition |
---|---|
T | |
Tx | Primary tumour cannot be assessed, or tumour proven by non-radiological means (sputum or bronchial washings) and cannot be visualised with imaging (or bronchoscopy) |
T0 | No primary tumour |
Tis | Carcinoma in situ (squamous or adenocarcinoma) |
T1 | Tumour ≤3 cm in greatest dimension |
T1a T1b T1c |
Tumour ≤1 cm |
Tumour >1 cm but ≤2 cm | |
Tumour >2 cm but ≤3 cm | |
T2 | Tumour >3 cm but ≤5 cm or tumour involving the main bronchus (regardless of the distance from the carina), the visceral pleura, with partial or complete lung atelectasis or pneumonitis |
T2a T2b |
Tumour >3 cm but ≤4 cm in greatest dimension |
Tumour >4 cm but ≤5 cm in greatest dimension | |
T3 | Tumour >5 cm but ≤7 cm in greatest dimension or one that directly invades: parietal pleura, chest wall (including superior sulcus tumours), phrenic nerve, parietal pericardium, or separate tumour nodule or nodules in the same lobe |
T4 | Tumour measuring >7 cm in greatest dimension or which invades mediastinum, diaphragm, heart, great vessels, trachea, recurrent laryngeal nerve, oesophagus, vertebral body, carina; or separate tumour nodule(s) in a different lobe of ipsilateral lung |
N | |
N0 | No regional lymph node metastases |
N1 | Ipsilateral peribronchial and/or ipsilateral hilar nodes and intrapulmonary nodes, including involvement by direct extension |
N2 | Ipsilateral mediastinal and/or subcarinal nodes |
N3 | Contralateral mediastinal, contralateral hilar, scalene, or supraclavicular nodes |
M | |
M0 | No distant metastases |
M1a | Separate tumour nodule(s) in the contralateral lung, malignant pleural effusion, pleural thickening/nodules or masses, malignant pericardial effusion/ pericardial thickening/nodules/masses |
M1b | Single extrathoracic metastasis in a single organ (including non-regional lymph nodes) |
M1c | Multiple extrathoracic metastases in a single organ or multiple organs |
NSCLC, non-small cell lung cancer.